Pure Financial Advisors, LLC

Position in EOLS — Evolus, Inc.

CIK 1571556 SAN DIEGO, CA

Position in EOLS

as of Mar 31, 2026 · filed Apr 10, 2026 Compact

Position Value

$73,959

-$44,411 QoQ

Shares Held

17,995

+1.1% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Pure Financial Advisors, LLC holds $775,771 across 5 Drug Manufacturers - Specialty & Generic names. EOLS ranks #4 (9.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	2,535	$333,960
2	TAK	Takeda Pharmaceutical Co Ltd	13,575	$251,409
3	AQST	Aquestive Therapeutics, Inc.	21,950	$91,092
4	EOLS	Evolus, Inc. This page	17,995	$73,959
5	CRON	Cronos Group Inc.	10,100	$25,351

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$73,959	17,995	+1.1%	Shares	Sole	2026-04-10
2025-12-31	$118,370	17,800	-0.2%	Shares	Sole	2026-02-04
2025-09-30	$109,500	17,834	—	Shares	Sole	2025-10-20
No filing history on record for this holder in this stock.